These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
444 related articles for article (PubMed ID: 20635312)
21. Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients. Li X; Lu Y; Pirzkall A; McKnight T; Nelson SJ J Magn Reson Imaging; 2002 Sep; 16(3):229-37. PubMed ID: 12205577 [TBL] [Abstract][Full Text] [Related]
22. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology. Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725 [TBL] [Abstract][Full Text] [Related]
23. The relationship between Cho/NAA and glioma metabolism: implementation for margin delineation of cerebral gliomas. Guo J; Yao C; Chen H; Zhuang D; Tang W; Ren G; Wang Y; Wu J; Huang F; Zhou L Acta Neurochir (Wien); 2012 Aug; 154(8):1361-70; discussion 1370. PubMed ID: 22729482 [TBL] [Abstract][Full Text] [Related]
24. [Value of proton magnetic resonance spectroscopy with two-dimensional chemical-shift imaging in evaluating brain gliomas]. Zhou GF; Wang XY; Gong CG; Liu F; Wang RW Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1342-4. PubMed ID: 18753055 [TBL] [Abstract][Full Text] [Related]
25. Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas. Li X; Jin H; Lu Y; Oh J; Chang S; Nelson SJ NMR Biomed; 2004 Feb; 17(1):10-20. PubMed ID: 15011246 [TBL] [Abstract][Full Text] [Related]
26. Comparison of unsupervised classification methods for brain tumor segmentation using multi-parametric MRI. Sauwen N; Acou M; Van Cauter S; Sima DM; Veraart J; Maes F; Himmelreich U; Achten E; Van Huffel S Neuroimage Clin; 2016; 12():753-764. PubMed ID: 27812502 [TBL] [Abstract][Full Text] [Related]
27. Integration of biochemical images of a tumor into frameless stereotaxy achieved using a magnetic resonance imaging/magnetic resonance spectroscopy hybrid data set. Stadlbauer A; Moser E; Gruber S; Nimsky C; Fahlbusch R; Ganslandt O J Neurosurg; 2004 Aug; 101(2):287-94. PubMed ID: 15309921 [TBL] [Abstract][Full Text] [Related]
28. Metabolic approach for tumor delineation in glioma surgery: 3D MR spectroscopy image-guided resection. Zhang J; Zhuang DX; Yao CJ; Lin CP; Wang TL; Qin ZY; Wu JS J Neurosurg; 2016 Jun; 124(6):1585-93. PubMed ID: 26636387 [TBL] [Abstract][Full Text] [Related]
29. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes. Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081 [TBL] [Abstract][Full Text] [Related]
30. Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy. Floeth FW; Pauleit D; Wittsack HJ; Langen KJ; Reifenberger G; Hamacher K; Messing-Jünger M; Zilles K; Weber F; Stummer W; Steiger HJ; Woebker G; Müller HW; Coenen H; Sabel M J Neurosurg; 2005 Feb; 102(2):318-27. PubMed ID: 15739561 [TBL] [Abstract][Full Text] [Related]
31. Conventional and advanced magnetic resonance imaging in tumefactive demyelination. Saini J; Chatterjee S; Thomas B; Kesavadas C Acta Radiol; 2011 Dec; 52(10):1159-68. PubMed ID: 22025739 [TBL] [Abstract][Full Text] [Related]
32. Differentiation of SCA2 from MSA-C using proton magnetic resonance spectroscopic imaging. Boesch SM; Wolf C; Seppi K; Felber S; Wenning GK; Schocke M J Magn Reson Imaging; 2007 Mar; 25(3):564-9. PubMed ID: 17326083 [TBL] [Abstract][Full Text] [Related]
33. Correlation between choline and MIB-1 index in human gliomas. A quantitative in proton MR spectroscopy study. Matsumura A; Isobe T; Anno I; Takano S; Kawamura H J Clin Neurosci; 2005 May; 12(4):416-20. PubMed ID: 15925772 [TBL] [Abstract][Full Text] [Related]
34. Proton magnetic resonance spectroscopy of normal human brain and glioma: a quantitative in vivo study. Tong ZY; Toshiaki Y; Wang YJ Chin Med J (Engl); 2005 Aug; 118(15):1251-7. PubMed ID: 16117877 [TBL] [Abstract][Full Text] [Related]
35. In the assessment of supratentorial glioma grade: the combined role of multivoxel proton MR spectroscopy and diffusion tensor imaging. Zou QG; Xu HB; Liu F; Guo W; Kong XC; Wu Y Clin Radiol; 2011 Oct; 66(10):953-60. PubMed ID: 21663899 [TBL] [Abstract][Full Text] [Related]
36. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard. Tong Z; Yamaki T; Harada K; Houkin K Magn Reson Imaging; 2004 Jun; 22(5):735-42. PubMed ID: 15172069 [TBL] [Abstract][Full Text] [Related]
37. Quantitative assessment of gliomas by proton magnetic resonance spectroscopy. Oshiro S; Tsugu H; Komatsu F; Abe H; Onishi H; Ohmura T; Iwaasa M; Sakamoto S; Fukushima T Anticancer Res; 2007; 27(6A):3757-63. PubMed ID: 17970039 [TBL] [Abstract][Full Text] [Related]
38. Tissue characterization of glioma by proton magnetic resonance spectroscopy and perfusion-weighted magnetic resonance imaging: glioma grading and histological correlation. Toyooka M; Kimura H; Uematsu H; Kawamura Y; Takeuchi H; Itoh H Clin Imaging; 2008; 32(4):251-8. PubMed ID: 18603178 [TBL] [Abstract][Full Text] [Related]
39. Targeting regions with highest lipid content on MR spectroscopy may improve diagnostic yield in stereotactic biopsy. Ng WH; Lim T J Clin Neurosci; 2008 May; 15(5):502-6. PubMed ID: 18334298 [TBL] [Abstract][Full Text] [Related]
40. Magnetic resonance spectroscopy imaging (MRSI) and brain functional magnetic resonance imaging (fMRI) for radiotherapy treatment planning of glioma. Chang J; Thakur SB; Huang W; Narayana A Technol Cancer Res Treat; 2008 Oct; 7(5):349-62. PubMed ID: 18783284 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]